Fangfang Duan

990 total citations
53 papers, 682 citations indexed

About

Fangfang Duan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fangfang Duan has authored 53 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Fangfang Duan's work include Ferroptosis and cancer prognosis (11 papers), RNA modifications and cancer (8 papers) and Inflammatory Biomarkers in Disease Prognosis (8 papers). Fangfang Duan is often cited by papers focused on Ferroptosis and cancer prognosis (11 papers), RNA modifications and cancer (8 papers) and Inflammatory Biomarkers in Disease Prognosis (8 papers). Fangfang Duan collaborates with scholars based in China, United States and Hong Kong. Fangfang Duan's co-authors include Peike Peng, Jianxin Gu, Yuanyuan Ruan, Weicheng Wu, Miaomiao Shao, Wenyu Zhai, Mingming Zhang, Can Li, Xuefei Wang and Caiting Yang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Fangfang Duan

49 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangfang Duan China 15 317 209 182 164 128 53 682
Kien Pham United States 18 310 1.0× 187 0.9× 310 1.7× 160 1.0× 76 0.6× 33 764
Jiahong Tan China 13 393 1.2× 192 0.9× 168 0.9× 171 1.0× 98 0.8× 29 781
Chao Su China 18 571 1.8× 193 0.9× 206 1.1× 224 1.4× 144 1.1× 44 976
Zhonghua Chu China 17 461 1.5× 207 1.0× 227 1.2× 182 1.1× 69 0.5× 36 759
Beibei Ni China 15 480 1.5× 104 0.5× 133 0.7× 186 1.1× 70 0.5× 33 740
Souzan Najafi Iran 15 416 1.3× 92 0.4× 226 1.2× 254 1.5× 75 0.6× 35 726
Jianfeng Cui China 16 331 1.0× 88 0.4× 173 1.0× 166 1.0× 149 1.2× 46 736
Gang Nan China 16 432 1.4× 182 0.9× 148 0.8× 180 1.1× 144 1.1× 26 753
Huan Zhou China 15 382 1.2× 156 0.7× 278 1.5× 227 1.4× 112 0.9× 26 714
Pengbo Deng China 15 334 1.1× 153 0.7× 210 1.2× 228 1.4× 214 1.7× 39 712

Countries citing papers authored by Fangfang Duan

Since Specialization
Citations

This map shows the geographic impact of Fangfang Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangfang Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangfang Duan more than expected).

Fields of papers citing papers by Fangfang Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangfang Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangfang Duan. The network helps show where Fangfang Duan may publish in the future.

Co-authorship network of co-authors of Fangfang Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Fangfang Duan. A scholar is included among the top collaborators of Fangfang Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangfang Duan. Fangfang Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Wenkai, Fangfang Duan, Zhiguang Liu, et al.. (2025). BMI-stratified cutoff values for spinal sarcopenia in Chinese adults based on CT measures: a multicentre study. Journal of Orthopaedic Surgery and Research. 20(1). 365–365. 2 indexed citations
2.
Wei, Shanshan, et al.. (2024). Sesquiterpenes and α-pyrones from an endophytic fungus Xylaria curta YSJ-5. Phytochemistry. 220. 114011–114011. 7 indexed citations
5.
Wei, Shanshan, Chen Chen, Yanjiang Zhang, et al.. (2023). Xylarcurcosides A-C, three novel isopimarane-type diterpene glycosides from Xylaria curta YSJ-5. Carbohydrate Research. 535. 108987–108987. 2 indexed citations
6.
7.
Zhai, Wenyu, Fangfang Duan, Yaobin Lin, et al.. (2023). Pan-Immune-Inflammatory Value in Patients with Non-Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy. Journal of Inflammation Research. Volume 16. 3329–3339. 13 indexed citations
8.
Fu, Chen, Dong Yan, Ling Wang, et al.. (2023). High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis. Frontiers in Endocrinology. 14. 1117438–1117438. 8 indexed citations
9.
Duan, Fangfang, Chenge Song, Jiajia Huang, et al.. (2022). Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study. Journal of Oncology. 2022. 1–10. 1 indexed citations
10.
Hua, Xin, Fangfang Duan, Wenyu Zhai, et al.. (2022). A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Early-Stage Breast Cancer. SHILAP Revista de lepidopterología. 20 indexed citations
12.
Duan, Fangfang, Li Wang, Chang Jiang, et al.. (2022). The Iron-Inflammation Axis in Early-Stage Triple-Negative Breast Cancer. Frontiers in Cell and Developmental Biology. 10. 784179–784179. 2 indexed citations
13.
Zhai, Wenyu, Fangfang Duan, Li Gong, et al.. (2021). Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 769881–769881. 6 indexed citations
14.
Yuan, Jing, Fangfang Duan, Wenyu Zhai, et al.. (2021). An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer. International Journal of Women s Health. Volume 13. 1053–1064. 7 indexed citations
15.
Duan, Fangfang, Wenyu Zhai, Bei Zhang, & Shengjie Guo. (2020). Urachal carcinoma: Impact of recurrence pattern and lymphadenectomy on long‐term outcomes. Cancer Medicine. 9(12). 4166–4174. 16 indexed citations
16.
Xie, Hua, Song Tian, Yang Bai, et al.. (2019). Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations
17.
Duan, Fangfang, et al.. (2018). P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation. American Journal of Respiratory Cell and Molecular Biology. 60(2). 221–231. 25 indexed citations
18.
Zhao, Jing, Peng Shu, Fangfang Duan, et al.. (2016). Loss of OLFM4 promotes tumor migration through inducing interleukin-8 expression and predicts lymph node metastasis in early gastric cancer. Oncogenesis. 5(6). e234–e234. 23 indexed citations
19.
Wang, Lan, Jie Yin, Xuefei Wang, et al.. (2016). C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits. Gastroenterology. 150(5). 1183–1195.e16. 49 indexed citations
20.
Hu, Yanling, Zhike Liu, Fangfang Duan, et al.. (2016). Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma. World Journal of Gastroenterology. 22(24). 5558–5558. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026